nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A2—Citalopram—alcohol dependence	0.337	1	CbGbCtD
Thiabendazole—Numbness—Disulfiram—alcohol dependence	0.0219	0.0608	CcSEcCtD
Thiabendazole—Sensory loss—Disulfiram—alcohol dependence	0.021	0.0582	CcSEcCtD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.0185	0.0612	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.0153	0.0507	CbGpPWpGaD
Thiabendazole—Hepatic failure—Disulfiram—alcohol dependence	0.0147	0.0407	CcSEcCtD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.013	0.0431	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.0118	0.039	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.0111	0.0367	CbGpPWpGaD
Thiabendazole—Drowsiness—Disulfiram—alcohol dependence	0.0102	0.0282	CcSEcCtD
Thiabendazole—Jaundice—Disulfiram—alcohol dependence	0.00991	0.0275	CcSEcCtD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00977	0.0323	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00974	0.0323	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00971	0.0322	CbGpPWpGaD
Thiabendazole—Hypoaesthesia—Disulfiram—alcohol dependence	0.00908	0.0252	CcSEcCtD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.0083	0.0275	CbGpPWpGaD
Thiabendazole—Lymphadenopathy—Acamprosate—alcohol dependence	0.00762	0.0211	CcSEcCtD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00738	0.0244	CbGpPWpGaD
Thiabendazole—Lymphadenopathy—Naltrexone—alcohol dependence	0.00721	0.02	CcSEcCtD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00706	0.0234	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00684	0.0227	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00621	0.0206	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00619	0.0205	CbGpPWpGaD
Thiabendazole—CYP1A2—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.0059	0.0195	CbGpPWpGaD
Thiabendazole—Somnolence—Disulfiram—alcohol dependence	0.00576	0.016	CcSEcCtD
Thiabendazole—Fatigue—Disulfiram—alcohol dependence	0.00559	0.0155	CcSEcCtD
Thiabendazole—CYP1A1—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00547	0.0181	CbGpPWpGaD
Thiabendazole—Coordination abnormal—Citalopram—alcohol dependence	0.00546	0.0152	CcSEcCtD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00521	0.0172	CbGpPWpGaD
Thiabendazole—Hyperglycaemia—Acamprosate—alcohol dependence	0.00507	0.014	CcSEcCtD
Thiabendazole—Haematuria—Acamprosate—alcohol dependence	0.00477	0.0132	CcSEcCtD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00471	0.0156	CbGpPWpGaD
Thiabendazole—Asthenia—Disulfiram—alcohol dependence	0.00465	0.0129	CcSEcCtD
Thiabendazole—CYP1A1—Xenobiotics—CYP2E1—alcohol dependence	0.00458	0.0151	CbGpPWpGaD
Thiabendazole—Lymphadenopathy—Citalopram—alcohol dependence	0.00457	0.0127	CcSEcCtD
Thiabendazole—Hypoaesthesia—Acamprosate—alcohol dependence	0.00447	0.0124	CcSEcCtD
Thiabendazole—CYP1A1—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.0044	0.0146	CbGpPWpGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00436	0.0144	CbGpPWpGaD
Thiabendazole—Hepatic failure—Citalopram—alcohol dependence	0.00433	0.012	CcSEcCtD
Thiabendazole—Visual impairment—Acamprosate—alcohol dependence	0.00433	0.012	CcSEcCtD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00431	0.0143	CbGpPWpGaD
Thiabendazole—Dizziness—Disulfiram—alcohol dependence	0.00429	0.0119	CcSEcCtD
Thiabendazole—Tinnitus—Acamprosate—alcohol dependence	0.00419	0.0116	CcSEcCtD
Thiabendazole—Rash—Disulfiram—alcohol dependence	0.00409	0.0113	CcSEcCtD
Thiabendazole—Headache—Disulfiram—alcohol dependence	0.00406	0.0113	CcSEcCtD
Thiabendazole—Chills—Acamprosate—alcohol dependence	0.00403	0.0112	CcSEcCtD
Thiabendazole—Tinnitus—Naltrexone—alcohol dependence	0.00397	0.011	CcSEcCtD
Thiabendazole—Chills—Naltrexone—alcohol dependence	0.00382	0.0106	CcSEcCtD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00367	0.0121	CbGpPWpGaD
Thiabendazole—Angioedema—Acamprosate—alcohol dependence	0.00358	0.00992	CcSEcCtD
Thiabendazole—Leukopenia—Acamprosate—alcohol dependence	0.0035	0.00971	CcSEcCtD
Thiabendazole—Vision blurred—Naltrexone—alcohol dependence	0.00349	0.00968	CcSEcCtD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00349	0.0115	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—MAOB—alcohol dependence	0.00346	0.0114	CbGpPWpGaD
Thiabendazole—Convulsion—Acamprosate—alcohol dependence	0.00339	0.0094	CcSEcCtD
Thiabendazole—Angioedema—Naltrexone—alcohol dependence	0.00338	0.00938	CcSEcCtD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00332	0.011	CbGpPWpGaD
Thiabendazole—Confusional state—Acamprosate—alcohol dependence	0.00322	0.00893	CcSEcCtD
Thiabendazole—Convulsion—Naltrexone—alcohol dependence	0.00321	0.0089	CcSEcCtD
Thiabendazole—Anaphylactic shock—Acamprosate—alcohol dependence	0.00319	0.00886	CcSEcCtD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00312	0.0103	CbGpPWpGaD
Thiabendazole—Confusional state—Naltrexone—alcohol dependence	0.00305	0.00845	CcSEcCtD
Thiabendazole—Anorexia—Acamprosate—alcohol dependence	0.00304	0.00844	CcSEcCtD
Thiabendazole—Hyperglycaemia—Citalopram—alcohol dependence	0.00304	0.00842	CcSEcCtD
Thiabendazole—Anaphylactic shock—Naltrexone—alcohol dependence	0.00302	0.00838	CcSEcCtD
Thiabendazole—Hypotension—Acamprosate—alcohol dependence	0.00298	0.00828	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.00298	0.00825	CcSEcCtD
Thiabendazole—CYP1A1—Tryptophan metabolism—ALDH2—alcohol dependence	0.00294	0.00973	CbGpPWpGaD
Thiabendazole—Jaundice—Citalopram—alcohol dependence	0.00293	0.00811	CcSEcCtD
Thiabendazole—CYP1A2—Xenobiotics—CYP2E1—alcohol dependence	0.00292	0.00966	CbGpPWpGaD
Thiabendazole—Anorexia—Naltrexone—alcohol dependence	0.00288	0.00799	CcSEcCtD
Thiabendazole—Haematuria—Citalopram—alcohol dependence	0.00286	0.00794	CcSEcCtD
Thiabendazole—Somnolence—Acamprosate—alcohol dependence	0.00284	0.00787	CcSEcCtD
Thiabendazole—Dyspepsia—Acamprosate—alcohol dependence	0.00281	0.0078	CcSEcCtD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00281	0.00929	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—MAOA—alcohol dependence	0.0028	0.00926	CbGpPWpGaD
Thiabendazole—CYP1A2—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00279	0.00924	CbGpPWpGaD
Thiabendazole—Decreased appetite—Acamprosate—alcohol dependence	0.00278	0.0077	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—ADH6—alcohol dependence	0.00277	0.00915	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00275	0.00911	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00273	0.00905	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—MAOA—alcohol dependence	0.00272	0.00901	CbGpPWpGaD
Thiabendazole—Somnolence—Naltrexone—alcohol dependence	0.00269	0.00745	CcSEcCtD
Thiabendazole—Hypoaesthesia—Citalopram—alcohol dependence	0.00268	0.00744	CcSEcCtD
Thiabendazole—Feeling abnormal—Acamprosate—alcohol dependence	0.00263	0.0073	CcSEcCtD
Thiabendazole—Decreased appetite—Naltrexone—alcohol dependence	0.00263	0.00728	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00261	0.00724	CcSEcCtD
Thiabendazole—Fatigue—Naltrexone—alcohol dependence	0.00261	0.00722	CcSEcCtD
Thiabendazole—Visual impairment—Citalopram—alcohol dependence	0.0026	0.0072	CcSEcCtD
Thiabendazole—Erythema multiforme—Citalopram—alcohol dependence	0.00255	0.00707	CcSEcCtD
Thiabendazole—Abdominal pain—Acamprosate—alcohol dependence	0.00252	0.007	CcSEcCtD
Thiabendazole—Tinnitus—Citalopram—alcohol dependence	0.00251	0.00697	CcSEcCtD
Thiabendazole—Flushing—Citalopram—alcohol dependence	0.0025	0.00694	CcSEcCtD
Thiabendazole—Feeling abnormal—Naltrexone—alcohol dependence	0.00249	0.0069	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00247	0.00685	CcSEcCtD
Thiabendazole—Chills—Citalopram—alcohol dependence	0.00242	0.00671	CcSEcCtD
Thiabendazole—Abdominal pain—Naltrexone—alcohol dependence	0.00239	0.00662	CcSEcCtD
Thiabendazole—Hypersensitivity—Acamprosate—alcohol dependence	0.00235	0.00652	CcSEcCtD
Thiabendazole—CYP1A1—Tryptophan metabolism—CYP2E1—alcohol dependence	0.00235	0.00778	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00234	0.00774	CbGpPWpGaD
Thiabendazole—Asthenia—Acamprosate—alcohol dependence	0.00229	0.00635	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—ADH1A—alcohol dependence	0.00229	0.00759	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00227	0.0075	CbGpPWpGaD
Thiabendazole—Pruritus—Acamprosate—alcohol dependence	0.00226	0.00627	CcSEcCtD
Thiabendazole—Hypersensitivity—Naltrexone—alcohol dependence	0.00223	0.00617	CcSEcCtD
Thiabendazole—Vision blurred—Citalopram—alcohol dependence	0.00221	0.00613	CcSEcCtD
Thiabendazole—CYP1A2—Tryptophan metabolism—MAOB—alcohol dependence	0.0022	0.0073	CbGpPWpGaD
Thiabendazole—Diarrhoea—Acamprosate—alcohol dependence	0.00219	0.00606	CcSEcCtD
Thiabendazole—Asthenia—Naltrexone—alcohol dependence	0.00217	0.00601	CcSEcCtD
Thiabendazole—Angioedema—Citalopram—alcohol dependence	0.00214	0.00594	CcSEcCtD
Thiabendazole—Pruritus—Naltrexone—alcohol dependence	0.00214	0.00593	CcSEcCtD
Thiabendazole—Dizziness—Acamprosate—alcohol dependence	0.00211	0.00586	CcSEcCtD
Thiabendazole—Leukopenia—Citalopram—alcohol dependence	0.0021	0.00582	CcSEcCtD
Thiabendazole—Diarrhoea—Naltrexone—alcohol dependence	0.00207	0.00573	CcSEcCtD
Thiabendazole—Convulsion—Citalopram—alcohol dependence	0.00203	0.00564	CcSEcCtD
Thiabendazole—Vomiting—Acamprosate—alcohol dependence	0.00203	0.00563	CcSEcCtD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00202	0.00668	CbGpPWpGaD
Thiabendazole—Rash—Acamprosate—alcohol dependence	0.00201	0.00558	CcSEcCtD
Thiabendazole—Dermatitis—Acamprosate—alcohol dependence	0.00201	0.00558	CcSEcCtD
Thiabendazole—Headache—Acamprosate—alcohol dependence	0.002	0.00555	CcSEcCtD
Thiabendazole—Dizziness—Naltrexone—alcohol dependence	0.002	0.00554	CcSEcCtD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00199	0.00658	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—ADH4—alcohol dependence	0.00195	0.00645	CbGpPWpGaD
Thiabendazole—Confusional state—Citalopram—alcohol dependence	0.00193	0.00535	CcSEcCtD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00193	0.00638	CbGpPWpGaD
Thiabendazole—Vomiting—Naltrexone—alcohol dependence	0.00192	0.00533	CcSEcCtD
Thiabendazole—Anaphylactic shock—Citalopram—alcohol dependence	0.00191	0.00531	CcSEcCtD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00191	0.00632	CbGpPWpGaD
Thiabendazole—Rash—Naltrexone—alcohol dependence	0.00191	0.00528	CcSEcCtD
Thiabendazole—Dermatitis—Naltrexone—alcohol dependence	0.0019	0.00528	CcSEcCtD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.0019	0.00629	CbGpPWpGaD
Thiabendazole—Nausea—Acamprosate—alcohol dependence	0.0019	0.00526	CcSEcCtD
Thiabendazole—Headache—Naltrexone—alcohol dependence	0.00189	0.00525	CcSEcCtD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00187	0.00621	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—ALDH2—alcohol dependence	0.00187	0.00621	CbGpPWpGaD
Thiabendazole—Anorexia—Citalopram—alcohol dependence	0.00183	0.00506	CcSEcCtD
Thiabendazole—Nausea—Naltrexone—alcohol dependence	0.00179	0.00498	CcSEcCtD
Thiabendazole—Hypotension—Citalopram—alcohol dependence	0.00179	0.00496	CcSEcCtD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—MAOA—alcohol dependence	0.00178	0.0059	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—ADH6—alcohol dependence	0.00176	0.00584	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00174	0.00577	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GGT2—alcohol dependence	0.00173	0.00573	CbGpPWpGaD
Thiabendazole—Somnolence—Citalopram—alcohol dependence	0.0017	0.00472	CcSEcCtD
Thiabendazole—Dyspepsia—Citalopram—alcohol dependence	0.00169	0.00467	CcSEcCtD
Thiabendazole—Decreased appetite—Citalopram—alcohol dependence	0.00166	0.00462	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—ADH7—alcohol dependence	0.00166	0.00548	CbGpPWpGaD
Thiabendazole—Fatigue—Citalopram—alcohol dependence	0.00165	0.00458	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—GGT2—alcohol dependence	0.00159	0.00526	CbGpPWpGaD
Thiabendazole—Feeling abnormal—Citalopram—alcohol dependence	0.00158	0.00437	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Citalopram—alcohol dependence	0.00157	0.00434	CcSEcCtD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00154	0.0051	CbGpPWpGaD
Thiabendazole—Abdominal pain—Citalopram—alcohol dependence	0.00151	0.0042	CcSEcCtD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP2E1—alcohol dependence	0.0015	0.00496	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—ADH1A—alcohol dependence	0.00146	0.00484	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—ADH1B—alcohol dependence	0.00145	0.00481	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00144	0.00478	CbGpPWpGaD
Thiabendazole—Hypersensitivity—Citalopram—alcohol dependence	0.00141	0.00391	CcSEcCtD
Thiabendazole—Asthenia—Citalopram—alcohol dependence	0.00137	0.00381	CcSEcCtD
Thiabendazole—Pruritus—Citalopram—alcohol dependence	0.00135	0.00376	CcSEcCtD
Thiabendazole—Diarrhoea—Citalopram—alcohol dependence	0.00131	0.00363	CcSEcCtD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—GGT1—alcohol dependence	0.00129	0.00426	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00127	0.0042	CbGpPWpGaD
Thiabendazole—Dizziness—Citalopram—alcohol dependence	0.00127	0.00351	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—ADH4—alcohol dependence	0.00124	0.00411	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00123	0.00407	CbGpPWpGaD
Thiabendazole—Vomiting—Citalopram—alcohol dependence	0.00122	0.00338	CcSEcCtD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00121	0.00401	CbGpPWpGaD
Thiabendazole—Rash—Citalopram—alcohol dependence	0.00121	0.00335	CcSEcCtD
Thiabendazole—Dermatitis—Citalopram—alcohol dependence	0.00121	0.00334	CcSEcCtD
Thiabendazole—CYP1A1—Biological oxidations—MAOB—alcohol dependence	0.0012	0.00398	CbGpPWpGaD
Thiabendazole—Headache—Citalopram—alcohol dependence	0.0012	0.00333	CcSEcCtD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.0012	0.00396	CbGpPWpGaD
Thiabendazole—Nausea—Citalopram—alcohol dependence	0.00114	0.00315	CcSEcCtD
Thiabendazole—CYP1A2—Biological oxidations—ADH7—alcohol dependence	0.00106	0.0035	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—ALDH2—alcohol dependence	0.00102	0.00339	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00102	0.00337	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GGT2—alcohol dependence	0.00101	0.00335	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000982	0.00325	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—ADH1B—alcohol dependence	0.000926	0.00307	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000835	0.00276	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000835	0.00276	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000825	0.00273	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase II conjugation—GGT1—alcohol dependence	0.000819	0.00271	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2E1—alcohol dependence	0.000818	0.00271	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000808	0.00268	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000807	0.00267	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—MAOB—alcohol dependence	0.000767	0.00254	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—GGT1—alcohol dependence	0.000751	0.00249	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—MAOA—alcohol dependence	0.000673	0.00223	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	0.000653	0.00216	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000649	0.00215	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000532	0.00176	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	0.000532	0.00176	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000526	0.00174	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	0.000522	0.00173	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000514	0.0017	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GGT1—alcohol dependence	0.000479	0.00159	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADH6—alcohol dependence	0.000473	0.00157	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—POMC—alcohol dependence	0.000438	0.00145	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—MAOA—alcohol dependence	0.000429	0.00142	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—EP300—alcohol dependence	0.000416	0.00138	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000407	0.00135	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADH1A—alcohol dependence	0.000392	0.0013	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADH4—alcohol dependence	0.000333	0.0011	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADH6—alcohol dependence	0.000302	0.000998	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000288	0.000955	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADH7—alcohol dependence	0.000283	0.000938	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	0.00028	0.000928	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—POMC—alcohol dependence	0.000279	0.000925	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GGT2—alcohol dependence	0.000272	0.000899	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADH1A—alcohol dependence	0.00025	0.000827	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADH1B—alcohol dependence	0.000248	0.000822	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADH4—alcohol dependence	0.000212	0.000703	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MAOB—alcohol dependence	0.000206	0.000681	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000184	0.000609	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADH7—alcohol dependence	0.000181	0.000598	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDH2—alcohol dependence	0.000175	0.000579	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GGT2—alcohol dependence	0.000173	0.000573	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000168	0.000557	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADH1B—alcohol dependence	0.000158	0.000524	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GOT2—alcohol dependence	0.000149	0.000493	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2E1—alcohol dependence	0.00014	0.000463	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MAOB—alcohol dependence	0.000131	0.000435	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GOT1—alcohol dependence	0.000128	0.000425	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GGT1—alcohol dependence	0.000128	0.000425	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MAOA—alcohol dependence	0.000115	0.000381	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000112	0.00037	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDH2—alcohol dependence	0.000112	0.000369	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000107	0.000355	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GOT2—alcohol dependence	9.49e-05	0.000314	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2E1—alcohol dependence	8.92e-05	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GGT1—alcohol dependence	8.19e-05	0.000271	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GOT1—alcohol dependence	8.19e-05	0.000271	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—POMC—alcohol dependence	7.49e-05	0.000248	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MAOA—alcohol dependence	7.34e-05	0.000243	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	7.12e-05	0.000236	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—EP300—alcohol dependence	4.97e-05	0.000165	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—POMC—alcohol dependence	4.78e-05	0.000158	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—EP300—alcohol dependence	3.17e-05	0.000105	CbGpPWpGaD
